Monopoly Rights?

Decreases Prices??

KHN Exclusive: White House task force echoes Pharma proposals

President Donald Trump repeatedly talks tough about reining in the pharmaceutical industry, but his administration’s efforts to lower drug prices are shrouded in secrecy. 

To solve the crisis of high drug prices, the group discussed strengthening the monopoly rights of pharmaceuticals overseas, 

ending discounts for low-income hospitals and accelerating drug approvals by the Food and Drug Administration. 

The White House declined to comment on the working group. 

These recommendations would not lower drug prices, experts say. Such measures “would be like a firefighter spraying gasoline on your burning garage,” Prasad said.

 DYI:  Out right advocate for monopoly power whether here or oversees is affront to our free enterprise system and will no doubt end up furthering the pharmaceuticals oligarchs position enabling these corporations to increase prices at will.  The person named Prasad is absolutely correct if these proposal are enacted it will be throwing gasoline onto a raging fire.

Obama Care is only a small part of the problem for health care.  The real problem lies with the underlining medical companies who collude in order to price fix and form monopolies relentlessly pushing up prices at a 9% to 10% per year.  The Medical Industrial Complex is now costing Americans 20% of the entire U.S. economy.  When combined with the Military Industrial Complex and the Student Loan Debacle you don’t have to have a doctorate in economics to figure out why growth has been so slow.

DYI